Edwards Lifesciences Corp
corporate_fare Company Profile
Edwards Lifesciences Corp (NYSE:EW) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for EW at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- FTC Blocks Edwards Lifesciences' JenaValve Acquisition; Company Raises Full-Year EPS Guidance
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$6.07B
Net Income
$1.07B
Diluted EPS
$1.83
Op. Cash Flow
$1.6B
Free Cash Flow
$1.33B
Gross Profit
$4.73B
Operating Income
$1.26B
Cash & Equivalents
$2.94B
Total Debt
$598.3M
Debt / Equity
0.06×
Net Margin
17.7%
Shares Outstanding
580.7M sh
Source: 10-K · filed 2026-02-25 · accession 0001099800-26-000009
show_chartPrice Chart
Loading chart...
feed EW - Filings & News (Page 2)
EW
Jan 09, 2026, 6:51 PM EST
Price at Filing:
$85.13
Real-time Price:
$101.85
Change:
+$16.72 (+20%)
Market Cap:
$58.564B